4-Fluorobenzo[d]oxazol-2(3H)-one

Catalog No. :
ACHTOF310
CAS No. :
590422-12-1
Molecular Formula :
C7H4FNO2
Molecular Weight :
153.11

IUPAC Name:4-fluorobenzo[d]oxazol-2(3H)-one

4-Fluorobenzo[d]oxazol-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$102.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Fluorobenzo[d]oxazol-2(3H)-one
IUPAC Name4-fluorobenzo[d]oxazol-2(3H)-one
MDL No.MFCD11845131
Molecular FormulaC7H4FNO2
Molecular Weight153.11
SMILESO=C1OC2=CC=CC(F)=C2N1
InChI KeyDLNMLICVXVLIKO-UHFFFAOYSA-N
Synonym2(3H)-Benzoxazolone,4-fluoro-(9CI);4-Fluoro-1,3-benzoxazol-2(3H)-one;4-Fluorobenzo[d]oxazol-2(3H)-one;4-Fluoro-3H-benzooxazol-2-one;4-Fluorobenzoxazol-2(3H)-one;4-Fluoro-benzooxazol-2-ol;2(3H)-Benzoxazolone, 4-fluoro-;4-fluoro-3H-1,3-benzoxazol-2-one
CAS No.590422-12-1
PubChem CID45090556

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHTOF310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSLRE416 route compound structure diagram
    ACSLRE41653981-23-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHTOF310 route product structure diagram
    ACHTOF310590422-12-1 In Stock
Inquiry

2. ACHTOF310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACSLRE416 route compound structure diagram
    ACSLRE41653981-23-0 In Stock
  6. Then
  7. ACHTOF310 route product structure diagram
    ACHTOF310590422-12-1 In Stock
Inquiry

Comments (0)